GE Healthcare Ireland Limited

FDA Regulatory Profile

GE Healthcare Ireland Limited appears in FDA public data with 2 recalls, 0 510(k) clearances, 4 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-0448-2026, Class II) was initiated on March 24, 2026.

Summary

Total Recalls
2
510(k) Clearances
0
Inspections
4
Compliance Actions
0

Recent Recalls

NumberClassProductDate
D-0448-2026Class IIGE Healthcare Omnipaque (iohexol) Injection, 350 mg/mL (64.7%), Rx Only, Distributed by: GE HealthcaMarch 24, 2026
D-0447-2026Class IIGE Healthcare Omnipaque (iohexol) Injection, 300 mg/mL (64.7%), Rx Only, Distributed by: GE HealthcaMarch 24, 2026